Lincoln Pharmaceuticals Ltd. will halt trading following Q3 2026 results announcement Back
<p>Lincoln Pharmaceuticals Ltd. will close its trading window from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Practices & Procedures for Fair Disclosure.</p>